triazoles has been researched along with Hepatic Insufficiency in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nguyen, M; Sun, L; Wilson, DM; Yeh, LT; Zhou, D | 1 |
Bergman, AJ; Davies, MJ; Dilzer, SC; Herman, GA; Lasseter, KC; Luo, WL; Migoya, EM; Stevens, CH; Wagner, JA | 1 |
1 trial(s) available for triazoles and Hepatic Insufficiency
Article | Year |
---|---|
Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin.
Topics: Administration, Oral; Aged; Area Under Curve; Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Half-Life; Hepatic Insufficiency; Humans; Liver Function Tests; Male; Middle Aged; Pyrazines; Severity of Illness Index; Sitagliptin Phosphate; Triazoles | 2009 |
1 other study(ies) available for triazoles and Hepatic Insufficiency
Article | Year |
---|---|
The Effects of Special Patient Population Plasma on Pharmacokinetic Quantifications Using LC-MS/MS.
Topics: Allopurinol; Calibration; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Hepatic Insufficiency; Humans; Kidney; Liver; Oxypurinol; Reference Standards; Renal Insufficiency; Renal Reabsorption; Reproducibility of Results; Tandem Mass Spectrometry; Thioglycolates; Triazoles; Uricosuric Agents; Verapamil | 2019 |